Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service decompression & minimally invasive spine cases in Nevada: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 4% on average (250 state-years, 2020–2024): a close guide.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 30 | 1,579 | 42% |
| 2020 | 28 | 1,308 | 45% |
| 2021 | 26 | 1,325 | 48% |
| 2022 | 28 | 1,120 | 51% |
| 2023 | 21 | 996 | 54% |
| 2024 | 27 | 1,015 | 56% |
| 2025 from claims | – | 982 899–1,042 | 57% |
| 2026 forecast | – | 998 878–1,147 | 57% |
| 2027 forecast | – | 1,009 863–1,197 | 58% |
| 2028 forecast | – | 1,021 852–1,243 | 58% |
| 2029 forecast | – | 1,033 844–1,287 | 59% |
| 2030 forecast | – | 1,044 837–1,329 | 60% |
Laminotomy, laminectomy, interspinous devices; the MIS call point. Professional codes (what the surgeon bills): CPT 63030, 63047, 63020, 63045, 22867; the hospital bills MS-DRG 518, 519, 520.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 63% of the cases CMS names in Nevada; 17 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 31% inpatient hospital, 66% hospital outpatient, 4% surgery center. The share outside the hospital has moved +2 pts since 2019, so more of this market is decided in surgery centers and offices each year.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| California | 219 | 9,464−2.9%/yr | −2.9%/yr | 2.7 | 7% | 9,940 in 2030+0.8%/yr |
| Arizona | 72 | 2,817−4.1%/yr | −4.1%/yr | 3.7 | 14% | 3,290 in 2030+2.6%/yr |
| Washington | 74 | 2,627−4.8%/yr | −4.8%/yr | 3.3 | 17% | 2,680 in 2030+0.3%/yr |
| Colorado | 51 | 2,134−5.2%/yr | −5.2%/yr | 4.2 | 5% | 2,510 in 2030+2.7%/yr |
| Oregon | 37 | 1,701−5.1%/yr | −5.1%/yr | 3.9 | 38% | 1,710 in 20300%/yr |
| Utah | 31 | 1,147−5.6%/yr | −5.6%/yr | 5.1 | 16% | 1,350 in 2030+2.8%/yr |
| Idaho | 23 | 850−1.3%/yr | −1.3%/yr | 4.0 | 1% | 1,090 in 2030+4.3%/yr |
| Montana | 11 | 582−2.8%/yr | −2.8%/yr | 3.0 | 9% | 560 in 2030−0.8%/yr |
| Alaska | 10 | 347+2.1%/yr | +2.1%/yr | 2.9 | 13% | 440 in 2030+4.1%/yr |
| Wyoming | 9 | 291−5.7%/yr | −5.7%/yr | 2.6 | 10% | 280 in 2030−0.8%/yr |
| New Mexico | 7 | 252−12%/yr | −12%/yr | 1.1 | 0% | 350 in 2030+5.7%/yr |
| Hawaii | 7 | 223−1.7%/yr | −1.7%/yr | 1.7 | 12% | 130 in 2030−8.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 24 | 954−1.4%/yr | −1.4%/yr | 3.21.1× | 2% | 760 in 2030−3.7%/yr |
| Cervical fusion & disc arthroplasty | 3 | 375−6.4%/yr | −6.4%/yr | 1.31.0× | 0% | 370 in 2030−0.3%/yr |
| Kyphoplasty & vertebroplasty | 0 | 171−16%/yr | −16%/yr | 0.60.6× | 32% | 230 in 2030+5.1%/yr |
Decompression & minimally invasive spine in every state, and its device makers · Every procedure market in Nevada · Every state · Compare with California
Medtronic leads with 55% of company spending on these surgeons in 2025, +5 pts on 2024.
In 2025, 8 companies reported engagement with Nevada’s surgeons worth $76K in consulting, speaking, meals and travel tied to these products, about $2,812 per surgeon billing it. Royalties are left out.
FDA, last 12 months: 5 clearances and approvals in the category.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.